PCYOX1 and atherosclerosis: PCYOX1 inhibition may be beneficial for mitigating the H2O2-triggered oxidation of phospholipids within lipoproteins, potentially opening new therapeutic avenues for cardiovascular diseases like atherosclerosis (11).